US Remote Patient Monitoring Market

The report "US Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Forecast to 2030", is expected to reach USD 29.13 billion by 2030 from USD 14.15 billion in 2024, at a CAGR of 12.8% during 2024–2030.

US Remote Patient Monitoring Market - Forecast to 2030. Browse over 200 tables, 50 figures, and an in-depth TOC on the US remote patient monitoring market report. Early buyers will receive 10% customization on the report.

To know about the assumptions considered for the study download the pdf brochure

The growing number of elderly individuals and the increasing demand for cost-effective healthcare solutions are key drivers of the remote patient monitoring (RPM) market in the US. According to the Population Reference Bureau, US population aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. During this period, the share of seniors in the total population is projected to rise from 17% to 23%. For example, US companies such as Boston Scientific Corporation, Abbott, and Dexcom enhance RPM through digital biomarkers and AI-driven analytics. Government initiatives, including Medicare reimbursement for RPM services and the CMS Hospital-at-Home program, further accelerate adoption.

Device segment holds largest share in the US remote patient monitoring market by component in 2023.

Based on component, the US remote patient monitoring market has been segmented into devices, software and services. In 2023, device segment is estimated to hold the largest share in the US remote patient monitoring market. Recent innovations in the US remote patient monitoring (RPM) market such as in March 2024, Dexcom (US) receives FDA clearance for Stelo a glucose biosensor. The device is connected to a smartphone for continuous glucose monitoring. Furthermore, the American Hospital Association supports the remote care delivery across state lines. These initiatives collectively aim to enhance patient care through improved access and technology integration in healthcare systems.

Patients segment register the fastest growth in the US remote patient monitoring market by end user in 2023.

The patients segment registers the fastest growth in the US remote patient monitoring market due to the rising patient awareness, increase in the prevalence of chronic diseases rises, and growing preference for home health care. The advancements in wearable technology and mobile health applications have made it easier for patients to engage with their health data actively. For instance, in August 2023, GE HealthCare (US) received 510(k) clearance from the US FDA for its Portrait Mobile wireless and wearable monitoring solution that provides personalized view of partient vitals. The US RPM market is expanding further due to the rising demand for affordable healthcare solutions, especially as the aging population becomes increasingly comfortable with technology.

To know about the assumptions considered for the study request sample pages

Cardiology segment holds largest share in the US remote patient monitoring market by indication in 2023.

Based on indication, the US remote patient monitoring market has been segmented into cardiology, diabetes, oncology, neurology, sleep disorders, wellness improvement, respiratory disorders, mental health, and other indications. The cardiology segment holds the largest share in the US remote patient monitoring market due to the increase in the cardiovascular diseases, and advancements in products that provide real-time cardiac data. According to the American Heart Association, approximately 2,300 people die from cardiovascular diseases (CVDs) each day in the US alone and according to the WHO, every year, CVDs cause 17.9 million deaths worldwide. Further improvements, such as in June 2024, AliveCor, Inc. (US) announced FDA clearance for Kardia 12L ECG system that detect 35 cardiac determinations, including heart attacks, using a reduced leadset.

Some of the prominent players in the US remote patient monitoring market includes GE HealthCare (US), Oracle (US), Boston Scientific Corporation (US), VitalConnect (US), Abbott (US), Optum, Inc (US), Blue Spark Technologies (US), Lightbeam (US) and others.

Related Reports:

US Remote Patient Monitoring Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com